Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 11,689 | 9,761 | 11,956 | 4,335 | 9,385 |
| Cost of Goods | 1,955 | 2,037 | 2,019 | 2,333 | 3,280 |
| Gross Profit | 9,734 | 7,724 | 9,937 | 2,002 | 6,105 |
| Operating Expenses | 41,520 | 42,052 | 44,371 | 43,043 | 33,032 |
| Operating Income | -30,831 | -34,291 | -34,415 | -40,708 | -26,647 |
| Interest Expense | 231 | 6,382 | 12,723 | 8,421 | 2,792 |
| Other Income | -8,189 | -1,228 | -1,257 | -3,471 | -4,370 |
| Pre-tax Income | -39,251 | -41,901 | -48,395 | -52,600 | -33,809 |
| Net Income Continuous | -39,251 | -41,901 | -48,395 | -52,600 | -33,809 |
| Minority Interests | -759 | -601 | -941 | -5 | N/A |
| Net Income | $-38,492 | $-41,300 | $-47,454 | $-52,595 | $-33,809 |
| EPS Basic Total Ops | -130.69 | -2,678.17 | -54,487.95 | -132,861.50 | -3.00 |
| EPS Basic Continuous Ops | -133.26 | -2,717.14 | -55,572.23 | -132,879.90 | -2.62 |
| EPS Diluted Total Ops | -130.69 | -2,678.17 | -54,487.95 | -132,861.50 | -3.00 |
| EPS Diluted Continuous Ops | -133.26 | -2,717.14 | -55,572.23 | -132,879.90 | -2.62 |
| EPS Diluted Before Non-Recurring Items | -130.69 | -2,695.78 | -54,487.95 | -133,617.20 | -339,704.69 |
| EBITDA(a) | $-28,199 | $-18,697 | $-20,365 | $-33,724 | $-21,697 |